Quantifying the impact of real-world evidence: the sacubitril/valsartan experience

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Saif Rathore

Sandbar Life Sciences, Kankakee (United States of America)

3 More presentations in this session

Presentation thumbnail

In patients with heart failure with unplanned admission to hospital lack of improvement in quality-of-life 2 months after discharge identifies individuals at very high risk of readmission or death.

Mrs M. Mcginlay (Leeds, GB)

Abstract Slides Video

Presentation thumbnail

Impact of severe mitral regurgitation on patients with 'De Novo' heart failure and reduced ejection fraction: baseline characteristics and survival analysis

Mr M. Mejuto Blanco (Santiago de Compostela, ES)

Abstract Slides Video

Presentation thumbnail

Heart rate control in heart failure: insights from nationwide multicenter registry HEROES.

Professor J. Kasprzak (Lodz, PL)

Abstract Slides Video

Access the full session

Session thumbnail

Epidemiology, prognosis, and outcome in chronic heart failure (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Incidence of cardiovascular events following vericiguat initiation in patients with heart failure with or without a recent worsening heart failure event: a hospital-based real-world cohort study

Congress Presentation

Navigating the realms of SGLT2 inhibitors bridging clinical studies enthusiasm with practical realities

Congress Presentation

Analytical approaches to open label extension (OLE) after cardiovascular outocmes trials: Observations from the FOURIER and FOURIER-OLE trials

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources